ANTI-TUMOR EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-1 IN MICE TRANSPLANTED WITH DIFFERENT SYNGENEIC TUMORS

被引：33

作者：

BELARDELLI, F

CIOLLI, V

TESTA, U

MONTESORO, E

BULGARINI, D

PROIETTI, E

BORGHI, P

SESTILI, P

LOCARDI, C

PESCHLE, C

GRESSER, I

机构：

[1] IST SUPER SANITA,DEPT HEMATOL & ONCOL,I-00161 ROME,ITALY

[2] INST RECH SCI CANC,VIRAL ONCOL LAB,F-94802 VILLEJUIF,FRANCE

来源：

INTERNATIONAL JOURNAL OF CANCER | 1989年 / 44卷 / 06期

关键词：

D O I：

10.1002/ijc.2910440629

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1108 / 1116

页数：9

相关论文

共 37 条

[31] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
ROSENBERG, SA
LOTZE, MT
MUUL, LM
CHANG, AE
AVIS, FP
LEITMAN, S
LINEHAN, WM
ROBERTSON, CN
LEE, RE
RUBIN, JT
SEIPP, CA
SIMPSON, CG
WHITE, DE
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) : 889 - 897
[32] REGRESSION OF ESTABLISHED PULMONARY METASTASES AND SUBCUTANEOUS TUMOR MEDIATED BY THE SYSTEMIC ADMINISTRATION OF HIGH-DOSE RECOMBINANT INTERLEUKIN-2
ROSENBERG, SA
MULE, JJ
SPIESS, PJ
REICHERT, CM
SCHWARZ, SL
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) : 1169 - 1188
[33] SHIRAKAWA F, 1986, J IMMUNOL, V137, P551
[34] ERADICATION OF MOUSE MELANOMA BY COMBINED TREATMENT WITH RECOMBINANT HUMAN INTERLEUKIN-2 AND RECOMBINANT MURINE INTERFERON-GAMMA
SILAGI, S
DUTKOWSKI, R
SCHAEFER, A
[J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 315 - 322
[35] VAAGE J, 1987, CANCER RES, V47, P4296
[36] INFLUENCE OF THE ADMINISTRATION SCHEDULE ON THE THERAPEUTIC EFFECT OF INTERLEUKIN-2
VAAGE, J
PAULY, JL
HARLOS, JP
[J]. INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (04) : 530 - 533
[37] VAAGE J, 1988, CANCER RES, V48, P2193

← 1 2 3 4 →